Ignite Creation Date:
2025-12-24 @ 7:49 PM
Ignite Modification Date:
2026-03-02 @ 4:09 AM
Study NCT ID:
NCT00096304
Status:
TERMINATED
Last Update Posted:
2018-04-10
First Post:
2004-11-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer
Sponsor:
Medical University of South Carolina
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MUSC-100781
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None